Boston, November 6, 2008 - BOSTON, Nov. 6 /PRNewswire/ -- With the past quarter experiencing unprecedented market ups and downs, life sciences companies are re-evaluating performance metrics, targets, and overall spending. As a result, emerging compensation trends in this turbulent economy point to continued focus on "pay for performance," as well as enhanced discussion and scrutiny of executive compensation programs and processes.

For the complete article please visit:

http://www.bizjournals.com/prnewswire/press_releases/Massachusetts/2008/11/06/NETH089